2.Management of Hematologic Malignancies.
Journal of Korean Oncology Nursing 2008;8(1):67-75
No abstract available.
Hematologic Neoplasms
3.Clinical analysis of 8 cases on double primary malignancy associated with hematopoietic malignancy.
Young Geun RYU ; Hee Jong KIM ; Jeong Mae CHOI ; Won Young HUH ; Eun Hwa KIM ; Kwang Young LEE ; Min Chul KIM ; Moon Joong KIM ; Kwang Min LEE ; Chun Hee LEE
Korean Journal of Hematology 1992;27(1):97-104
No abstract available.
Hematologic Neoplasms*
5.Hematological malignancies complicating beta-thalassemia syndromes: a single center experience.
Samin ALAVI ; Alieh SAFARI ; Elham SADEGHI ; Somayeh AMIRI
Blood Research 2013;48(2):149-151
No abstract available.
beta-Thalassemia
;
Hematologic Neoplasms
6.Cellular immunotherapy as a beacon of hope for hematological malignancies.
Hyun Ju LEE ; Sang Ki KIM ; Duck CHO ; Je Jung LEE
Blood Research 2015;50(3):126-128
No abstract available.
Hematologic Neoplasms*
;
Hope*
;
Immunotherapy*
7.The Spectrum of Various Intracranial Manifestations in Leukemic Patients: A Pictorial Review.
Hae Jeong LEE ; Kookjin AHN ; Jeong Eun CHOI ; Jee Young KIM ; Jeong Whee LEE ; Hee Je KIM ; Dong Won YANG ; Seong Tae HAHN
Journal of the Korean Radiological Society 2006;54(3):147-154
The recent therapeutic advances for treating hematologic neoplasm have improved patients' survival, but these treatments have increased the frequency of neurologic complications and toxic effects. Most of the neurological features of leukemia are divided into three main categories: the primary effects of the disease, the treatment-related side effects and the infectious complications. The purpose of this pictorial assay is to document the radiologic abnormalities seen in the intracranial structures during and after the treatment of leukemia, and to aid in the clinical management of patients.
Hematologic Neoplasms
;
Humans
;
Leukemia
8.The premier statistical report of hematologic malignancies in Korea.
Korean Journal of Hematology 2012;47(1):1-2
No abstract available.
Hematologic Neoplasms
;
Korea
9.A multifaceted approach targeting NK cells for better treatment of cancer: focus on hematological malignancies.
Blood Research 2015;50(4):189-191
No abstract available.
Hematologic Neoplasms*
;
Killer Cells, Natural*
10.Progress of study on circulating microRNAs in hematologic malignancies.
Ying QU ; Hai-Yan HE ; Jian HOU
Journal of Experimental Hematology 2014;22(1):219-222
MicroRNAs (miRNAs) are a class of endogenous small non-coding RNAs that play an important role in the pathogenesis and progression of tumor. Recently, it is discovered that circulating microRNA exist stably in body fluids, such as serum/plasma, cerebrospinal fluid, saliva, urine, breast milk and so on. Circulating microRNA profiles now have been associated with different hematologic malignancy types, disease states and prognosis. They may serve as a new class of non-invasive diagnostic or prognostic biomarkers, and even the potential therapeutic targets in hematologic malignancies. In this article, the circulating miRNA, existent pattern and function of circulating miRNA, and circulating miRNA and hematologic malignancies are reviewed.
Hematologic Neoplasms
;
genetics
;
Humans
;
MicroRNAs
Result Analysis
Print
Save
E-mail